pulmonary hypertension and drugs Flashcards

1
Q

Normal mean pulmonary pressure

A

10-14 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pulmonary hypertension: (value)

A

more than 25 mmHg at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pulmonary hypertension results in …. (Histology)

A
  1. arteriosclerosis 2. medial hypertrophy 3. intimal fibrosis
    OF PULMONARY ARTERIES
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pulmonary hypertension - course

A

severe respiratory distress –> cyanosis and RVH –>

death from decompensated cor pulmonale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

classification group of pulmonary hypertension - number

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

classicfication group of pulmonary hypertension - based on

A

cause and treatment options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PH

A

pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which are the classicfication group of pulmonary hypertension

A
  1. pulmonary arterial hypertension (PAH)
  2. PH due to left heart disease
  3. PH due to lung disease or hypoxia
  4. chronic thromboembolic PH
  5. multifactorial PH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

multifactorial pulmonary hypertensions - causes

A
  1. hematologic disorders
  2. systemic disorders
  3. metabolic disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

chronic thromboembolic pulmonary hypertensions - pathophysiology

A

recurrent microthrombi –> decreased sectional area of pulmonary vascular bed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pulmonary hypertensions due to lung disease or hypoxia - pathophysiology

A
  1. destruction of lung parenchyma

2. hypoxemic vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pulmonary hypertensions due to lung disease or hypoxia - destruction of lung parenchyma example

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pulmonary hypertensions due to lung disease or hypoxia - hypoxemic vasoconstriction

A
  1. obstructive sleep apnea

2. living in high altitude

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pulmonary hypertensions due to left heart disease - is often due to

A
  1. systolic dysfunction
  2. diastolic dysfunction
  3. valvular disease such as mitral stenosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pulmonary arterial hypertension (PAH) - idiopathic - prognosis

A

poor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pulmonary arterial hypertension (PAH) - causes

A
  1. idiopathic
  2. drugs
  3. connective tissue disease
  4. HIV infection
  5. portal hypertension
  6. congenital heart disease
  7. schistosomiasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

pulmonary arterial hypertension (PAH) - idiopathic - pathophysiology

A

often due to inactivation mitation in BMPR2 gene

18
Q

BMPR2 gene - normal action

A

inhibits vascular SMCs proliferation

19
Q

pulmonary arterial hypertension (PAH) also includes

A
  1. pulmonary venous occlusive disease

2. persistent PH of newborn

20
Q

pulmonary arterial hypertension (PAH) - drugs that cause it

A
  1. amphetamines

2. cocaine

21
Q

idiopathic pulmonary arterial hypertension (PAH) - special feature

A

heritable

22
Q

pulmonary hypertension drugs - categories

A
  1. endothelin receptor antagonists
  2. PDE-5 inhibitors
  3. Prostacyclin analogs
23
Q

pulmonary hypertension drugs - categories and drugs

A
  1. endothelin receptor antagonists –> BOSENTAN
  2. PDE-5 inhibitors –> SILDENAFIL
  3. Prostacyclin analogs –> EPOPROSTENOL, ILOPROST
24
Q

pulmonary hypertension drugs - endothelin receptor antagonists - drug and toxicity

A

bosentan

hepatotoxicity

25
Q

pulmonary hypertension drugs - endothelin receptor antagonists - monitor

A

monitor LFTs

26
Q

pulmonary hypertension drugs - endothelin receptor antagonists - drug and mechanism of action

A

Bosentan: competitively antagonize endothelin-1 receptors –> decreases pulmonary vascular resistance

27
Q

pulmonary hypertension drugs - PDE-5 inhibitors - drugs

A

sildenafil (viagra)

28
Q

pulmonary hypertension drugs - PDE-5 inhibitors - mechanism of action

A

inhibit cGMP PDE5 and prolong vasodilatory effect of nitric oxide

29
Q

pulmonary hypertension drugs - PDE-5 inhibitors - they also used for

A

erectile dysfunction

30
Q

sildenafil - used for

A
  1. pulmonary hypertension

2. erectile dysfunction

31
Q

prostacyclin analogs side effects

A
  1. flushing

2. jaw pain

32
Q

prostacyclin analogs for pulmonary hypertension - drugs

A
  1. epoprostenol

2. iloprost

33
Q

prostacyclin analogs for pulmonary hypertension - mechanism of action

A

prostacyclins (PGI2) with direct vasodilatory effects on pulmonary and systemic arterial vascular beds
inhibit platelet aggregation

34
Q

pulmonary hypertension treatment - categories

A
  1. endothelin receptor antagonists –> BOSENTAN
  2. PDE-5 inhibitors –> SILDENAFIL
  3. Prostacyclin analogs –> EPOPROSTENOL, ILOPROST
35
Q

pulmonary hypertension treatment - drug with hepatotoxicity

A

bosentan

36
Q

hiv infection - type of pulmonary hypertension

A

pulmonary arterial hypertension

37
Q

type of pulmonary hypertension with poor prognosis

A

pulmonary arterial hypertension

38
Q

obstructive sleep apnea - type of pulmonary hypertension

A

PH due to lung disease or hypoxia

39
Q

portal hypertension - type of pulmonary hypertension

A

pulmonary arterial hypertension

40
Q

pulmonary hypertension treatment - categories

A
  1. endothelin receptor antagonists –> BOSENTAN
  2. PDE-5 inhibitors –> SILDENAFIL
  3. Prostacyclin analogs –> EPOPROSTENOL, ILOPROST